By Femtech Insider News, Pharma, Regulatory September 5, 2025 ShareTwitterFacebookPinterest-circled FDA Approves Henlius-Organon Denosumab Biosimilars for Osteoporosis and Bone Cancer Treatment
By Femtech Insider Maternal Health, News, Pharma, Research August 19, 2025 ShareTwitterFacebookPinterest-circled Reunion Neuroscience Reports Positive Phase 2 Results for Psychedelic Postpartum Depression Treatment
By Femtech Insider Cancer, News, Pharma, Regulatory August 15, 2025 ShareTwitterFacebookPinterest-circled AbbVie Receives UK MHRA Approval for Ovarian Cancer Treatment ELAHERE
By Femtech Insider News, Pharma, Reproductive Health July 17, 2025 ShareTwitterFacebookPinterest-circled Daré Bioscience Reports Positive Contraception Trial Results as Smart Drug Delivery Platform Shows Broader Potential
By Femtech Insider Menopause, News, Pharma July 16, 2025 ShareTwitterFacebookPinterest-circled Bayer Receives First Global Approval for Lynkuet to Treat Menopause Vasomotor Symptoms
By Femtech Insider Endometriosis, News, Pharma July 2, 2025 ShareTwitterFacebookPinterest-circled Organon Discontinues Endometriosis Drug Development After Failed Phase 2 Trial
By Kathrin Folkendt Ecosystem, Medical Device, News, Pharma June 9, 2025 ShareTwitterFacebookPinterest-circled The Organization That Made History: How Medicines360’s New Innovation Hub Is Scaling Access-First Women’s Health Solutions
By Femtech Insider Cancer, News, Pharma May 20, 2025 ShareTwitterFacebookPinterest-circled Merck’s Immunotherapy Shows Survival Benefit in Platinum-Resistant Ovarian Cancer Trial
